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Vision: 
To provide a national focus for all knowledge related efforts that inform Irish policy in relation to drug misuse.
Mission: 
The NACD has undertaken to:
n	Support the Government in significantly reducing the health, social and economic consequences of drug 
misuse through the provision of timely data and analysis of research;
n	Review its knowledge base, identifying gaps which can be addressed through research;
n	Ensure that evidence from scientific research forms the basis for policy formulation, development of 
services and continuous improvement in all its approaches to tackling drug misuse in Ireland; 
n	Work closely with the Drug Misuse Research Division of the Health Research Board, providing advice, 
coordinating research efforts and maximising the use of resources;
n	Support and promote the National Documentation Centre; 
n	Liaise with the relevant agencies nationally in order to co-ordinate research and resources;
n	Ensure participation nationally of a broad range of parties in fulfilling its research needs and dissemination 
of findings; 
n	Serve all drug misuse reduction activities in providing for an effective dissemination of research findings, 
information and other data thus linking research to practice.
Values: 
The NACD agreed that the following values would guide the implementation of its work programme.  
The NACD will:
n	manage the diversity of its membership and commit to a consensus approach in decision-making;
n	foster a culture of respect, dignity, transparency and fairness in all its operations:
n	be objective in the collection and dissemination of information in line with its commitment to the  
National Drugs Strategy 2001-2008;
n	Commit to the highest possible standards of excellence and ethical conduct;
n	Seek out collaborations and partnerships where there is greater benefit to achieving its goal and  
co-operate with everyone who can benefit from its knowledge base. 
 
Fís: 
Fócas náisiúnta a sholáthar i gcomhair na n-iarrachtaí uile a bhaineann le heolas agus a threoraíonn beartais 
na hÉireann maidir leis an mí-úsáid drugaí.
Misean: 
Ghabh an CCND air féin na nithe seo a leanas a dhéanamh: 
n	Tacú leis an Rialtas chun iarmhairtí na mí-úsáide drugaí ó thaobh na sláinte, na sochaí agus an 
gheilleagair, a laghdú go suntasach trí shonraí tráthúla agus anailís ar thaighde a sholáthar; 
n	Athbhreithniú a dhéanamh ar bhonn a chuid eolais agus bearnaí ar féidir aghaidh a thabhairt orthu trí 
thaighde a shonrú;
n	Cinntiú gur fianaise ó thaighde eolaíochta a bheidh ina bhunús le beartais a cheapfar, seirbhísí a 
fhorbrófar agus le feabhas leanúnach ar gach ceann dá chur chuigeanna chun dul i ngleic leis an mí-úsáid 
drugaí in Éirinn;
n	Oibriú go dlúth le Rannán Taighde ar Mhí-Úsáid Drugaí an Bhoird Taighde Sláinte, ag soláthar comhairle, 
ag comhordú iarrachtaí taighde agus ag uasmhéadú na húsáide a bhainfear as acmhainní;
n	Tacú leis an Ionad Doiciméadaithe Náisiúnta agus é a chur chun cinn;
n	Oibriú in éineacht leis na gníomhaireachtaí ábhartha ar bhonn náisiúnta chun taighde agus acmhainní a 
chomhordú;
n	Rannpháirtíocht raon leathan páirtithe a chinntiú ar bhonn náisiúnta ó thaobh a chuid riachtanas taighde 
a chomhlíonadh agus torthaí a scaipeadh; 
n	Freastal ar na gníomhaíochtaí uile a bhaineann leis an mí-úsáid drugaí a laghdú agus soláthar á 
dhéanamh go scaipfear torthaí taighde, faisnéis agus sonraí eile go héifeachtach, rud a nascfaidh taighde 
leis an gcleachtas.
Luachanna: 
Chomhaontaigh an CCND go mbeadh na luachanna seo a leanas ina dtreoir dó agus a chlár saothair á chur 
i bhfeidhm. 
Déanfaidh an CCND na nithe seo a leanas: 
n	éagsúlacht a bhallraíochta a bhainistiú agus tiomantas a dhéanamh do chur chuige comhthola agus cinntí 
á ndéanamh; 
n	cultúr measa, dínite, trédhearcachta agus cothroime a chothú ina chuid oibríochtaí uile; 
n	a bheith oibiachtach agus faisnéis á bailiú agus á scaipeadh, ar aon dul lena thiomantas do Stráitéis 
Náisiúnta Drugaí 2001-2008;
n	Tiomantas a dhéanamh do na caighdeáin is airde is féidir ó thaobh feabhais agus na hiompraíochta eiticiúla; 
n	Comhoibrithe agus comhpháirtíochtaí a thóraíocht sa chás gur mó an tairbhe a bheidh ann ó thaobh a 
sprioc a bhaint amach agus comhoibriú le gach duine a d’fhéadfadh leas a bhaint as bonn a chuid eolais. 
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It gives me great pleasure to welcome this – the second 
progress report of the National Advisory Committee 
on Drugs (NACD) – since it was established in 2000.
The NACD fulfils the very important role of advising 
Government in relation to prevalence, prevention, 
treatment and consequences of problem drug use 
in Ireland. The value of the NACD became evident 
in the recent mid-term review of the National Drugs 
Strategy. Findings and recommendations emerging 
from NACD research were integrated into this review 
process. Gaps in the research and knowledge identified 
in the first work programme of the NACD continue to 
contribute valuable insights to Government. Research 
is one of the five pillars of the National Drugs Strategy 
200–2008 that clearly reflects the importance of 
having good quality data and information underpinning 
policymaking in this difficult and complex area.
The evaluation of the NACD by Talbot Associates, 
commissioned by my department, found that the 
NACD provided excellent value for money. The 
Government was pleased to extend the mandate of the 
NACD up to 2008. In the remaining period to 2008 
the NACD will implement recommendations from the 
evaluation and continue to develop and expand its 
work programme.
I am very pleased that this Progress Report provides an 
opportunity to highlight the broad range of research 
projects that have been carried out – or are on-going 
– under the Committee’s stewardship. I want to 
congratulate the Committee and its Chairperson,  
Dr Des Corrigan, for the efficient and professional 
manner in which it has carried out its work to date. 
I also want to acknowledge the strong commitment 
shown by members from across the various sectors 
represented on the Committee. The body of work 
produced to date is all the richer for their input and 
expertise. I wish the Committee well in the future and 
look forward over the coming months to seeing the 
results of the many studies they have commissioned.
NoelAhernTD 
Minister of State with responsibility for the  
National Drugs Strategy
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It is my privilege to present this report on the 
activities of the NACD to the Minister of State with 
responsibility for the National Drugs Strategy. In 
doing so, I thank him and his officials in the Drugs 
Strategy Unit of the Department of Community, Rural 
and Gaeltacht Affairs for their continuous support 
of our work. The Minister has always been available 
to us for briefings and we are grateful to him for his 
commitment to the work of the NACD. 
The hard work of the staff of the NACD and of the 
Committee’s members is reflected in the high quality 
Reports and Bulletins which have appeared since 
2003. These publications cover all aspects of our remit 
from Government and are testimony to the input of 
a dedicated and incredibly hard working Secretariat 
allied to the intensely professional and committed 
expertise of members of the Committee. I thank them 
all for their enthusiasm and expertise. In particular 
I want to express the appreciation we all feel for our 
director, Mairéad Lyons. Her energy, commitment and 
hard work are infectious and I feel privileged through 
having the opportunity to work with her. 
The successful completion of so much of our work 
programme is due to her drive and vision. As this 
Report demonstrates, the NACD has produced a 
significant body of relevant work and has, I believe, 
established itself as a key component of the National 
Drugs Strategy. Our work programme has benefited 
enormously from the views expressed by the large 
number of stakeholders who contributed ideas and 
proposals during the consultation process. 
My colleagues and I are confident that we can build on 
the successful outcomes of the past few years and that 
we will continue to provide information and advice 
that is timely, relevant and makes a real contribution 
to achieving the goals of our National Drugs Strategy. 
DrDesCorrigan
Chairperson
CHAIRPERSON’S REPORT
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This is the second report of the NACD on its research 
activities from August 2003 to December 2005 
inclusive. This progress report bears testimony to its 
many achievements and accomplishments. This has 
been a very productive time for the NACD with much 
research completed and other research in progress 
which substantially contributes to understanding 
problem drug use in Ireland. 
During this period the NACD has systematically built 
on the solid foundation of its first three years of work; 
20 research reports have been published and research 
has been and is being commissioned in a number of 
important areas. Credit for these accomplishments 
is due to the hard work and expertise of not only the 
Committee and the staff of the NACD, but also to 
those who carried out and participated in research on 
drug misuse; an issue that affects every person in Irish 
society. In addition to the work of their substantive 
posts the Committee members give on average three 
days per month to NACD business. 
Gaps in information and knowledge about problem 
drug use in Ireland are being dealt with in a methodical 
and meticulous manner through internal and external 
research to ensure that up to date data and evidence 
are made available to government to inform drugs 
related policy in Ireland. The NACD continues in 
its mission to bring an evidence based approach 
to drugs policy and practice in Ireland. This period 
also saw the construction and development of the 
NACD website which has made a significant and 
meaningful contribution to raising public awareness 
and understanding about problem drug use. Chapters 
One to Three of this report give the background of 
the Committee, its Work Programme and a list of 
completed research during the period August 2003 to 
December 2005. Chapter Four explores the important 
area of Communication. Chapter Five describes 
ongoing research and a summary of the External 
Review of the NACD is presented in Chapter Six. 
It was particularly rewarding and affirming to receive 
such a positive evaluation of the work of the NACD 
from Talbot Associates and to receive a renewal of its 
mandate. It reinforced the commitment of the NACD 
to pursue gaps in knowledge for all the stakeholders 
whom we serve.
I feel continuously privileged to work with the NACD 
and its Chairperson, Dr Desmond Corrigan whose 
interest, drive, expertise and enthusiasm continue 
to facilitate the work of the NACD. I owe a debt 
of gratitude to former Research Officer, Dr Aileen 
O’Gorman who left after four years to pursue interests 
in UCD. I thank Muiris Ó Conchuir, Alan Gaffney, 
Declan Crean and Mary Jane Trimble, former and 
current Office Managers and Secretariat, respectively 
for their commitment and effort in achieving the goals 
of the NACD. Appreciation is extended also to Martha 
Doyle for her work on the DTMS, to Úna Molyneux 
for her work as a Research Assistant and Catherine 
Darmody for her work on web development and other 
IT matters in the NACD.
MairéadLyons
Director
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MsCatherineDarmody– Production
MrAlanGaffney– Production
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BYAP Ballymun Youth Action Project
CDTL Central Drug Treatment List
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OJEC Official Journal of the European 
Community
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This is the second progress report of the National 
Advisory Committee on Drugs (NACD) which presents 
the goals and achievements of the NACD from August 
2003 to December 2005. 
Origins
The NACD was established on a non-statutory basis 
in 2000 for an initial period of three years which was 
subsequently extended to a fourth year ending in July 
2004. Following an external review of the NACD its 
mandate was renewed. The NACD is under the auspices 
of the Department of Community, Rural and Gaeltacht 
Affairs and reports to the Minister of State with 
responsibility for the National Drugs Strategy 200-2008.
Functions
On its establishment, the functions of the NACD (the 
Committee) were set out as follows:
n	Based on the Committee’s analysis and 
interpretation of research findings and information 
available to it, to advise the Cabinet Committee on 
Social Inclusion and, through it, the Government, 
in relation to the prevalence, prevention, treatment 
and consequences of problem drug use in Ireland;
n	To review current information and research capacity 
in relation to the prevalence, prevention, treatment 
and consequences of problem drug use in Ireland 
and to make recommendations, as appropriate, on 
how deficits should be addressed including how to 
maximise the use of information available from the 
community and voluntary sector;
n	To oversee the delivery of a three year prioritised 
programme of research and evaluation as 
recommended by the Interim Advisory Committee 
to meet the gaps and priority needs identified by:
a) using the capacity of relevant agencies engaged 
in information gathering and research, both 
statutory and non-statutory, to deliver on 
elements of the programme;
b) liaising with these agencies with a view to 
maximising the resources allocated to delivering 
the programme and avoiding duplication;
c) co-ordinating and advising on research projects 
in the light of the prioritised programme;
d) commissioning research projects which cannot 
be met through existing capacity.
n	To commission additional research at the request  
of the Government into drug issues of relevance  
to policy;
n	To work closely with the Health Research Board 
(HRB) on the establishment of a national 
information/research database (in relation 
to the prevalence, prevention, treatment and 
consequences of problem drug use) which is easily 
accessible; and
n	To advise relevant agencies with a remit to promote 
greater public awareness of the issues arising in 
relation to problem drug use and to promote and 
encourage debate through the dissemination of its 
research findings.
Chapter One
BACKGROUND AND FUNCTIONS  
OF THE NACD
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TheNACD
How does the NACD achieve its aims? The success 
of the NACD is largely due to its broad based 
committee system. The membership of the NACD 
reflects the range of different perspectives in the 
field of drug misuse. The members serve at the 
invitation of the Minister of State and have been 
drawn from the statutory, community, voluntary 
and academic research sectors together with senior 
level representation from the relevant Government 
Departments. 
Sub-Committees
Emerging from the main committee are five sub-
committees (see appendix 2) who examine relevant 
issues relating to problem drug use, in the areas of 
prevalence, prevention, treatment, consequences and 
early warning/emerging trends. These sub-committees 
have enabled the NACD to address an extensive 
research programme. Their work involves framing 
appropriate research questions, commissioning 
research, reviewing draft reports prior to sending them 
to the committee for consideration. 
WorkProgramme/Meetings
Implementation of the work programme requires 
considerable work from the committee. Between 
July 2003 and December 2005, there were sixteen 
main committee meetings and each meeting lasted 
three hours. In addition, each member sits on an 
average of two sub-committees as well as individual 
Research Advisory Groups. The various subcommittees 
(Consequences, Prevention, Treatment, Prevalence and 
EWET) have also held between 2 and 6 meetings 
each. On average ,000 hours per person have been 
given to NACD and sub-committee meetings, at the 
very least this amounts to 43 days over two and a half 
years, averaging five days a month. For the Director 
and Research Officer it represents almost a third of 
their workload. 
TermsofReference
Terms of reference for each sub-committee may 
include the following key responsibilities:
n	Evaluate and determine the research needs for a 
specific sector or area of focus;
n	Agree the research approach and agenda;
n	Formulate the key research questions;
n	Review and, if appropriate, approve research 
proposals;
n	Monitor progress on research projects;
n	Support the development of position papers to  
the NACD.
The current work programme of the NACD has guided 
the actions of the Committee, its sub-committees  
and staff. 
Consequences
The aim of the consequencessub-committee is to 
examine the impact of drug problems on society in 
terms of: 
n	drug related deaths; 
n	the effect of drugs on the family and communities; 
n	the relationship between drugs and crime; 
n	the methods for tackling social nuisance related to 
drug misuse. 
Early Warning and Emerging Trends
The aim of the earlywarningandemergingtrends
sub-committee is:
n	To receive, share and monitor on behalf of the 
NACD, information from national and EU sources 
on New Synthetic Drugs of concern in the context 
of the Council Decision of 2005/387/JHA on 
information exchange, risk assessment and control 
of new psychoactive substances.
Chapter Two
WORK PROGRAMME –  
STRUCTURES AND MEMBERSHIP
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n	To receive, share and monitor on behalf of the 
NACD, information on emerging trends and 
patterns in drug use particularly polydrug use and 
associated risks;
n	To monitor the pilot project on emerging trends 
being developed at EU level, to assess its relevance 
to Ireland and whether it should be implemented in 
this country;
n	To report to the NACD on a quarterly basis about 
emerging trends and New Synthetic Drugs, but 
more frequently if circumstances warrant it. 
Prevalence
The aim of the prevalencesub-committee is:
n	To determine the size and nature of drug problems 
in Ireland; 
n	To determine the extent and nature of opiate 
use, poly-drug use and patterns of drug use 
(experimental, occasional, regular, non-medical 
and problem use) particularly among young people 
under 25;
n	To identify emerging trends and geographical 
spread; 
n	To determine the extent and nature of problem use 
of prescription drugs; 
n	To determine the prevalence of drug misusers not in 
contact with treatment services.
Prevention
The aim of the preventionsub-committee is:
n	To examine the effectiveness in terms of impact 
and outcomes of existing prevention models and 
programmes, with particular regard to evaluation 
instruments developed at European level;
n	To undertake comparative studies of different 
models with particular reference to those in 
operation in Local Drug Task Force (LDTF) and 
Regional Drug Task Force (RDTF) areas; 
n	To determine transferability of models among 
different target groups. 
Treatment/Rehabilitation
The aim of the treatment/rehabilitation
sub-committee is: 
n	To examine the effectiveness in terms of impact and 
outcomes of existing treatment and rehabilitation 
models and programmes;
n	To examine the impact of the treatment setting;
n	To examine the context in which relapse occurs; 
n	To undertake longitudinal studies of the 
effectiveness of existing treatment and rehabilitation 
models. 
ManagingResearch
In addition to the internal research programme, the 
NACD commissions an extensive amount of research 
externally through the public tendering process. 
Research Advisory Groups are established for every 
external project. Completion of contracted research is 
made possible with the support of the many agencies 
external to the NACD such as local health authorities, 
the Drug Treatment Centre Board, An Garda Síochána, 
hospital and voluntary/community groups. These 
agencies gather data and make it available to the NACD.
The Process
The NACD gathers information through its 
relationship with a range of agencies and service 
providers in the field of drug addiction, through 
commissioning research and through carrying out 
internal research itself. The commissioning process 
goes through seven stages where the NACD: ) 
agree the research question, 2) agree the design/
methodology best suited to address the question, 3) 
prepare a tender brief, 4) issue the request for tenders, 
5) award the contract, 6) agree the project objectives 
document and 7) address any conflict of interests.
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Once the research is completed the researcher starts a 
report drafting process in which the NACD or a named 
sub group act as peer reviewers to ensure the quality of 
the document and findings. 
A draft final report is then submitted to the NACD 
and it then considers and deliberates over a period 
of time which will vary depending on the volume of 
work or indeed the complexity of the issue. The NACD 
will finally agree recommendations to Government 
and with that a publication process is initiated. Not 
all reports are published and this is determined by 
several factors: whether the report provides any new 
information, whether it is simply to inform internal 
deliberations on planning or whether the research is 
weak or flawed in the methodology or analysis. It is the 
desire of the NACD to achieve as many publications 
arising from research it commissions as is possible and 
to disseminate that research to its key stakeholders in 
Government. The NACD engages in extensive efforts to 
disseminate findings from its research through media 
release, briefing seminars and conferences.
Research Advisory Groups
The primary role of the Research Advisory Group is to 
guide and manage research projects from inception to 
completion. Terms of reference include the following:
. Monitor and support the research through each 
stage of development;
2. Agree the project objectives document;
3. Inform the research process and agree the 
development or enhancement/changes to the design;
4. Provide practical advice where difficulties emerge 
during the various stages of research;
5. Ensure ethical approval is obtained where necessary 
from the relevant research ethics committee;
6. Observe the publication and copyright policy of the 
NACD as stated in the NACD contracts;
7. Review drafts of progress and final reports 
providing feedback where appropriate re the needs 
of the NACD in terms of content for consideration 
and publication; 
8. Report to the NACD and the appropriate sub-
committee on progress of research projects;
9. Sign off on the final draft of the report to be 
submitted to the NACD for approval and agreement 
on recommendations to be made to Government.
Between August 2003 and December 2005 there were 
on average 60 meetings of the Research Advisory 
Groups (Consequences, Prevention, Treatment and 
Prevalence). The meetings lasted two hours with an 
average of four hours preparation time. In addition, 
there were four meetings of research advisory groups 
with recipients of the Community/Voluntary Sector 
Research Grant Scheme. 
Collaboration
A key function of the NACD is to liaise with external 
agencies to maximize the resources allocated to 
delivering the programme. The NACD is actively 
involved with the National Drugs Strategy and has 
presented recommendations to them based on 
research evidence. Other external agencies which the 
NACD are involved with include Combat Poverty 
Agency and the UK Research and Information Working 
Group (RIWG).
The RIWG is facilitated by the Home Office in the UK. 
Ireland participates by invitation to share knowledge 
and exchange ideas. Its aim is research collaboration 
and the promotion of good practice when developing 
drugs research and monitoring information in the UK 
(including Wales, Scotland and Northern Ireland) 
and the Republic of Ireland. These discussions 
have direct benefit to the development of good 
practice here. RIWG meetings are held quarterly. The 
NACD’s participation in RIWG has resulted in the 
development of valuable networks which have greatly 
enhanced its work.
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Business Plan 2005-2008
Arising from a Government decision to renew the 
NACD mandate, a second work programme has been 
developed. A consultation process was undertaken 
with key interest groups and stakeholders to explore 
further research and information opportunities. The 
plan has incorporated the continuation of the current 
programme set out above and the identification of 
ongoing gaps in our knowledge. Two new priority areas 
for development in line with Government priorities are 
Rehabilitation and Drugs and Crime research. 
The Work Programme for 2005-2008 was restructured 
to include the following four key elements:
n	Commissioned research 
n	Grant-aided research 
n	Internal research 
n	Communications 
It also reflects the time and resource requirements 
for necessary professional development work and for 
management and administration within the NACD.
Commissioned Research
Research is one of the four pillars of the National 
Drugs Strategy 200-2008, clearly reflecting the 
importance of having information and evidence to 
underpin policy-making in this diverse field. The 
commissioned research programme focuses on 
the completion of current research projects, on 
undertaking a limited number of ‘follow through’ or 
repeat projects, and on exploring areas of potential 
research, particularly in rehabilitation and drugs and 
crime. Gaps in knowledge and information regarding 
evidence based practice are best filled through 
commissioned research. 
Grant-aided Research
Grant-aided research is also a potential means of 
developing the knowledge and skills required both to 
undertake and manage research activities. The NACD 
develops this aspect through the implementation of a 
focused programme of research supports including the 
continuation of its existing Community and Voluntary 
Sector Research Grant Schemes and supporting 
the Regional and Local Drug Task Force research 
initiatives. 
Internal Research
Internal research capacity has been developed to 
implement the Drug Trend Monitoring System (DTMS) 
to meet the objectives set out under the Programme 
for Government and the National Drugs Strategy for 
the identification of new or emerging drug trends. 
This initiative is currently being piloted. Focus will also 
be given to publication of ‘position papers’ that will 
provide timely insights for Government into current 
drug-related issues.
Communications 
The functions of the NACD necessitate communication 
for many different reasons and at different levels.  
A Communications strategy has been put in place 
to optimize the impact of the various initiatives and 
outputs, in terms of provision of advice, dissemination 
of findings and promotion of the research agenda.  
The objectives of the communications strategy are:
n	To provide timely advice and briefings to the 
Minister on key issues and emerging trends;
n	To advise service providers and practitioners across 
sectors of relevant research findings that may 
inform current thinking and practice;
n	To promote the research agenda amongst key 
influencers in those agencies and bodies that 
promote, commission, fund or undertake drug-
related research and/or have access to relevant data 
in this field; 
n	To represent the NACD and Ireland at  
international fora.
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SummaryofNACDresearchtoDecember2005
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The NACD completed several research projects 
between August 2003 and December 2005. 
Publication represents the culmination of a research 
process. The actual research will have been undertaken 
over a specified period and subjected to a detailed 
review by the Committee prior to publication. These 
publications are listed in chronological order. 
1.October2003
Drug Use in Ireland and Northern Ireland First results from 
the 2002/2003 Drug Prevalence Survey. Bulletin  NACD 
and the Drug and Alcohol Information and Research 
Unit (DAIRU) within the Department of Health, Social 
Services and Public Safety in Northern Ireland. 
2.October2003
Drug Use in Ireland and Northern Ireland – First Results from 
the 2002/2003 Drug Prevalence Survey – A Summary of the 
Methodology. NACD and DAIRU.
3.December2003
Use of Lofexidine in the Management of Opiate Dependence 
Syndrome. The National Medicines Information Centre 
at St James’s Hospital. 
4.December2003
Use of Naloxone in the Management of Opiate Dependence 
Syndrome. The National Medicines Information Centre 
at St James’s Hospital. 
5.December2003
An Overview of Cocaine Use in Ireland. NACD.
6.February2004
Progress Report – July 2000 to July 2003. NACD.
7.March2004
Prevalence of Opiate Use in Ireland 2000-2001. A 3-Source 
Capture Recapture Study. Dr Alan Kelly, University of 
Dublin, Trinity College. 
8.April2004
Drug Use in Ireland and Northern Ireland 2002/2003 Drug 
Prevalence Survey: Health Board (Ireland) & Health 
and Social Services Board (Northern Ireland) Results 
Bulletin 2. NACD and DAIRU. 
9.May2004
A Review of Harm Reduction Approaches in Ireland and 
Evidence from the International Literature. Dublin City 
University.
10.September2004
An Overview of Scientific and other Information on Cannabis. 
Dr Mark Morgan, Head of the Education Department 
at St. Patrick’s College, Drumcondra, Dr Claire 
Collins, Research Director of Social and Clinical 
Research Consultants (SCRC), Mr Johnny Connolly, 
Criminologist and Research Officer with the Drug 
Misuse Research Division of the Health Research 
Board and Dr Dominique Crowley, Specialist in Public 
Health Medicine. 
11.October2004
Benzodiazepines – whose little helper? The role of 
Benzodiazepines in the development of substance misuse 
problems in Ballymun. Ballymun Youth Action Project 
(BYAP). 
12.October2004
A prevalence study of drug use by young people in a mixed 
suburban area. Kilbarrack Coast Community Programme 
(KCCP). 
13.October2004
Drug use among new communities in Ireland: An Exploratory 
Study. Merchants Quay Ireland.
14.October2004
Heroin – the mental roof over your head. Links between 
Homelessness and Drug Use. Tallaght Homeless Advice Unit.
Chapter Three
NACD PUBLICATIONS 
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15.November2004
Mental Health and Addiction Services and the Management of 
Dual Diagnosis in Ireland. School of Nursing, Dublin City 
University.
16.November2004
The Role of Family Support Services in Drug Prevention. 
Unique Perspectives.
17.April2005
Drug Use Among the Homeless Population in Ireland. 
Merchants Quay Ireland. 
18.June2005
Drug Use in Ireland and Northern Ireland – First Results 
(Revised) from the 2002/2003 Drug Prevalence Survey. 
Bulletin 1. NACD and DAIRU.
19.June2005
Drug Use in Ireland and Northern Ireland 2002/2003 Drug 
Prevalence Survey: Health Board (Ireland) & Health and  
Social Services Board (Northern Ireland). Results (Revised) 
Bulletin 2. NACD and DAIRU.
20.October2005
Drug Use in Ireland and Northern Ireland. 2002/2003 Drug 
Prevalence Survey: Cannabis Results. Bulletin 3. NACD and 
DAIRU.
21.November2005
Business Plan 2005-2008. NACD (website only). 
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During the period under report (August 2003 to 
December 2005), the NACD has published 20 reports 
and provided advice to Government. The NACD executes 
two of its core functions – namely to provide advice 
and to promote and encourage debate through the 
dissemination of its research findings – via the publication 
and dissemination of its research. The Committee 
communicates the results of research undertaken to a 
wide and varied audience including government ministers, 
senior government officials, political representatives, 
policy makers, service providers, experts, community 
interest groups, the research community and the media. 
This requires the NACD to present information that 
is clear and accessible to a range of people. All report 
publications include an Executive Summary that enables 
a quick understanding of the study and its outcomes. 
Furthermore, to enhance the distribution of the results 
of research undertaken, publication of reports is 
supported by media relations activity and seminars. 
AdvicetoGovernment
A key function of the Committee is, on the basis of 
analysis and interpretation of research findings and 
information available to it, to advise the government, 
in relation to the prevalence, prevention, treatment 
and consequences of problem drug use in Ireland. 
In addition to the advice provided by research 
publications the following specific areas are direct 
requests from government:
n	At the request of the Minister of State and 
under Action 98 of the National Drugs Strategy, 
the NACD undertook research on drug use 
among vulnerable groups such as the Homeless 
and Travellers. The NACD made a series of 
recommendations to Government to develop and 
improve services for homeless drug users which 
informed the development of a new strategy on 
homelessness. The recommendations covered four 
key areas: policy and planning, drug treatment, 
harm reduction, and accommodation and housing. 
n	The NACD expect to provide advice in 2006 on 
drug treatment outcomes for opiate users.
n	Action 00 of the National Drugs Strategy required 
research to be carried out on Harm Reduction 
Approaches in Ireland and internationally. 
Recommendations were made to the Government 
regarding the availability and access to harm reduction 
programmes including needle exchange services. 
n	Research on cannabis was commissioned to provide 
an overview of the scientific and other information 
available. Recommendations have been made 
to Government. In particular, the report drew 
attention to the harmful consequences of smoking 
cannabis and the need to monitor the potency of 
cannabis products in Ireland. 
n	As part of the programme for Government, the 
NACD established a pilot Drug Trend Monitoring 
System, which captured information from a wide 
range of sources on drug trends. A report was 
submitted with the recommendation to implement 
a drug trend monitoring system in Ireland. 
This matter is still under consideration by the 
Government. 
n	The NACD was requested to provide a briefing 
document to Government on Drug Rehabilitation 
to support the development of a 5th pillar in 
the National Drugs Strategy. The briefing which 
comprised a literature review and analysis was 
provided in September 2005.
n	Arising from changes in the Health, Safety and 
Welfare at Work Act, 2005, the NACD were 
invited to advise Government in relation to 
the development of Regulations on Workplace 
Drug Testing through participation in the HSA 
consultative process. 
n	The Chairperson of the NACD attends the IDG and 
provides advice directly at this forum on issues such 
as the Drug Related Deaths Surveillance System.
Chapter Four
COMMUNICATION 
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TheNACDWebsite–www.nacd.ie
The website has been substantially revised and was 
launched in May 2004 acting as a valuable tool for 
information dissemination. This initiative was the 
outcome of a rewarding team effort by the NACD staff 
who collaborated with external design consultants. 
The website is clear and accessible and provides a 
comprehensive listing of links with information on drug 
use, treatment and research from Ireland, the UK and 
further afield. The information is presented bilingually 
through the medium of the English and Irish language.
The home page provides information about the NACD, 
their work programme, news and events, publications, 
research activities, research funding and links to other 
useful organisations. The site is an important resource 
because it offers the possibility to download relevant 
reports and policy documents. Information is regularly 
updated. 
The name, address and phone number of the NACD is 
clearly presented thus facilitating communication from 
a wide audience. Queries are regularly received and 
dealt with by staff. Potential users employing search 
engines such as Google or Yahoo will find a link to the 
NACD by typing in keywords such as ‘drugs’, ‘Ireland’. 
MediaRelations
As noted, media relations activity is an important 
communications tool of the NACD to primarily 
ensure that the results and recommendations of the 
NACD’s publications are effectively disseminated 
to its audiences and stakeholders. Secondly, media 
relations activity also serves to ensure a greater level of 
informed debate and dialogue in the sector in order to 
encourage solutions to Ireland’s drug problems. In this 
regard, press briefings and seminars are hosted by the 
NACD and press releases are distributed to coincide 
with the publication of various reports. 
The complexity of the drugs issue leads to challenges 
in effectively communicating the results and 
recommendations of NACD publications. To meet 
this challenge, the NACD hosts media briefings in 
conjunction with the publication of reports. Each 
briefing includes a question and answer session 
in which the NACD endeavours to respond to any 
questions about aspects of its reports. A press release 
outlining the report’s key results and the NACD’s 
recommendations arising from the report is also 
distributed to the media. All press releases are posted 
on the website and are also translated into Irish.
Between August 2003 and December 2005, eleven 
press releases were distributed to a wide range of print 
and broadcast media. If requested, representatives 
of the NACD have provided interviews to print and 
broadcast journalists, which journalists have used for 
sound bites on national and regional radio and TV 
news bulletins. NACD representatives also participate 
extensively in interviews on current affairs programmes 
throughout Ireland’s national and regional radio 
network. For example, between September 2004 and 
September 2005, approximately fifteen interviews were 
provided to current affairs programmes on regional 
radio stations. 
The following examples demonstrate how effectively 
the results of NACD publications are dispersed across 
a broad spectrum of media outlets. 
The publication and launch of the report, ‘Drug Use 
Among the Homeless Population in Ireland’ in April 
2005 resulted in coverage in seven national papers 
(The Irish Times, Irish Independent, Irish Examiner, The 
Star, Irish Mirror, Irish Sun and Daily Ireland) including 
reporting in The Irish Times on two different days. 
Director of the NACD, Mairead Lyons also participated 
in a panel discussion on RTE Radio One’s Tonight with 
Vincent Browne. Various sound bites were broadcast, 
with quotes from the Minister, the Chairperson and 
the Director, throughout the day of the launch of the 
report on: national radio stations, RTE One, 2FM 
and Today FM; Dublin stations, Newstalk 06, Q02, 
98FM, FM 04 and regional stations via Independent 
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Network News (INN); INN syndicates news bulletins 
to Ireland’s 28 regional radio stations throughout the 
country. 
The publication of the NACD/DAIRU 2002/2003 Drug 
Prevalence Survey: Cannabis Results also generated 
coverage in all national and tabloid newspapers. 
Including on line media (e.g. Ireland.com), a total of 
ten news articles were published. The print coverage 
was news driven and was given space on the opening 
news pages of each paper. The country’s major 
broadcasters, RTE, TV3 and SKY also covered the 
launch. Throughout the day of the launch, a total of 
3 news bulletins (national and regional) reported the 
report’s key results. Some stations continued to cover 
the issue for a number of days. 
SeminarsandPresentations
Seminars
Between August 2003 and December 2005, 8 seminars 
were held. These seminars were opened by the Minister 
of State with responsibility for the National Drugs 
Strategy, Mr Noel Ahern TD and mostly chaired by Dr 
Des Corrigan, Chairperson of the NACD. The Director 
and/or the Research Officer made presentations on 
the work of the NACD to various networks in public 
health and social sciences. Invitations were extended 
to Government departments, Drugs Strategy Unit, 
National Drugs Strategy Team, Regional Drugs Task 
Forces, Local Drugs Task Forces, statutory drug 
services, community drug services/groups and voluntary 
drugs services, family support network, Citywide Drug 
Crisis Campaign and the media.
Where relevant, invitations were extended to other 
specialist sectors such as the mental health sector and 
the homeless sector and are noted in the summaries. 
With an average attendance of 00 people, the 
seminars have provided a platform for the problem 
drug use sector to network, share information, 
experiences and knowledge. 
Given the small number of staff in the NACD, 
organizing seminars placed a substantial burden on 
the workload of the office. A decision was taken in 
2004 to host media briefings in future and to host 
seminars less frequently. 
Presentations to Key Audiences
In fulfilling the NACD’s mission to link research to 
practice and the value of co-operating with everyone 
who can benefit from its knowledge base, the Director 
or Research Officer regularly give lectures and 
presentations.
2003
n	Addiction, The Wheel, Carmichael House, September.
n	Overview of Drugs in Ireland, Merchants Quay Ireland/
University College Dublin, September.
n	Drug Use Prevention: An Overview of Research,  
Addiction Studies, Adult Education Course,  
Co. Wicklow, November.
n	Drug Use Prevalence in Ireland, Regional Drugs Task 
Force Conference, Heritage Hotel, Portlaoise,  
November.
n	Population Survey presentation, December.
n	Cocaine Seminar, Mont Clare Hotel, December.
n	The Work of the NACD presentation to Drug 
Treatment in Prisons Working Group, December.
2004
n	City Wide Family Support Network, Mansion House, 
Dublin, April (Launch of Directory). 
n	Lecture to Students on M.A. Addiction Studies in 
Dublin Business School, April. 
n	EU National Drug Coordinators Meeting, June.
n	Information briefing to Regional Drugs Task Force 
in NAHB (Axis Centre), July.
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n	South Eastern Regional Drugs Task Force Prevalence 
Workshop, Kilkenny, September.
2005
n	Drug Awareness Programme, January.
n	Lecture to Students on M.A. Addiction Studies in 
Dublin Business School, April. 
n	Drug Testing Monitoring System – Prelimary Report of 
Pilot Study to LDTFs and RDTFs, April.
n	‘Addiction’, Lecture to students on M. Sc. Addiction 
Studies, Trinity College, June. 
n	Drug Treatment Centre Board, July.
n	Key issues relating to Best Practice in Drug Rehabilitation, 
Presentation to Rehab Working Group, September.
n	Drugs and Families – Shared Perspectives, Shared 
Solutions, Barnardos and Merchants Quay Ireland 
Training Programme, Parkgate Hall, Conyngham 
Road, Dublin 7, November. 
n	Commissioning and Managing Research, seminar to 
LDTF, December. 
CoursesandConferences
Courses Attended (August 2003-December 2005)
In order to meet the demands of research publication, 
the NACD ensures that staff receive training and 
development in essential software applications such as: 
Microsoft Word, Excel, Access, Powerpoint, Outlook 
and Statistical Package for the Social Sciences. 
Freedom of Information Training Workshops, Finance 
and Governance and Writing Skills courses were also 
attended. 
Conferences and Seminars attended  
(August 2003 - December 2005)
To keep well informed and up to date with 
developments nationally and internationally in the 
field of substance misuse, the Director and/or the 
Research Officer attended relevant conferences 
which also provide opportunities for networking and 
communication.
2003
. The Substance of Youth: Alcohol and Drug Use Amongst 
Young People, 3rd Annual Conference, Addiction 
Research Centre, Trinity College, Dublin, September. 
2. Cocaine Use in Northern Ireland – myth or reality?  
The Rosspark Hotel, Kells, Co. Meath, September.
3. Emerging Trends, British Irish Conference (BIC), 
Guernsey, September.
4. European Society for Social Research on Drugs 
(ESSD), 4th International Conference, October. 
Hosted by the Institute for Social Drug Research 
(ISD) Department of Criminal Law and Criminology 
of the Faculty of Law, University of Ghent, Belgium. 
5. Forum on the Workplace of the Future, Achieving High 
Performance in Irish Workplaces, International Research 
Conference, Croke Park, November. 
6. Drug Prevention Conference, Bray, Co. Wicklow, 
November.
2004
7. Connecting Research, policy and practice: Lessons learned, 
challenges ahead, Strategic Conference, Strasbourg, 
(Pompidou Group, Co-Operation Group to Combat 
Drug Abuse and Illicit Trafficking in Drugs), February.
8. Injecting Practices of Injecting Drug Users, Drug Misuse 
Information Scotland, Scottish Executive, Effective 
Intervention Unit, February. 
9. Police Co-Operation Party EU Aegis Programme,  
A Multi-agency response to Cocaine related Crime and 
Social Problems, An Garda Síochána, March.
0. EU Strategy on Drugs – the way Forward, Irish EU 
Presidency Conference, Dublin Castle, May.
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. Towards a Comprehensive System for Treating Alcohol-
Related Problems, 4th Annual Conference,  
Addiction Research Centre Trinity College Dublin, 
September. 
2.  European Society for Social Drug Research (ESSD),  
5th Annual Conference, Munich, Germany,  
October.
2005
3. Conference: Darkness on the Edge of Town: Heroin 
Misuse in Athlone and Portlaoise, Athlone Institute of 
Technology, January. 
4. Seminar on Quality of Mental Health – Your views, 
hosted by Mental Health Commission, Burlington 
Hotel, Dublin 4, February. 
5. 16th International Conference on the Reduction of Drug 
Related Harm, Belfast, Northern Ireland, March.
6. Evaluation of the Work of the Blanchardstown Equal 
Initiative 2002-2005, Blanchardstown Equal 
Initiative, May. 
7. British Irish Council, Edinburgh, May.
8. Conference to launch The Development of a National 
Set of Child Well-Being Indicators, Westbury Hotel, 
Dublin, June. 
9. Vital Connections, Local Drugs Task Forces Leading 
the Response, Royal Hospital Kilmainham, 
October.
20. European Society for Social Drug Research (ESSD),  
6th Annual Conference, Town Hall, Albert 
Square, Manchester, UK, October.
2. Health Inequalities on the Island of Ireland –  
An Agenda for Change! Creating Connections, 
Glenroyal Health, Maynooth, Co. Kildare,  
November.
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In addition to the research already published, the 
NACD has commissioned a number of other studies.
OngoingCommissionedExternal
Research
Evaluation of the NACD Pilot Community and 
Voluntary Sector Research Grant Scheme 
An evaluation of the NACD Pilot Community and 
Voluntary Sector Research Grant Scheme was 
carried out by Kate Ennals Associates. A draft of the 
report was received in November 2005 and is under 
consideration by the NACD.
Community Study
A two year Community Study was completed by Dr 
Hilda Loughran and Dr Mary Ellen McCann from the 
Department of Social Policy and Social Work in UCD. 
The goals of the community study were set out in the 
tender to capture the experiences of communities of 
the drug problem since 996 with a view to informing 
the development of a set of community indicators of a 
community drug problem. A final draft of the report was 
provided to the NACD in November 2005 and Executive 
Summary in December 2005 for its consideration. 
Publication is expected in mid to late 2006. 
Families – Experiences of support
This qualitative study examined the experiences of 
families seeking support to cope with problem opiate 
use on the part of one or more family members. The 
overall objective of the study was to develop greater 
understanding of the ways in which families, and in 
particular, the person in the family with the primary 
caring role, sought support; their expectations in 
doing so and their perception of the adequacy or 
effectiveness of the responses they received. This 
research was carried out by Dr Carmel Duggan of 
WRC Social and Economic Consultants. A report was 
submitted to the NACD on the st of November 2005. 
A progress report and an outline of a draft report was 
submitted in December 2005 and will be considered 
with a view to publication in mid 2006.
2002/2003 Drug Prevalence Study
The first Drug Prevalence Survey in Ireland was 
commissioned by the NACD and DAIRU in 2002 and 
undertaken by MORI MRC. Its aim is to establish the 
extent and pattern of drug misuse on the whole island 
of Ireland; Bulletins  and 2 were released in 2003. 
Bulletin 3 which focused on cannabis use and attitudes 
to cannabis was published in 2005 which will be 
followed by Bulletins 4, 5 and 6 in 2006.
Research Outcome Study in Ireland Evaluating a 
drug treatment effectiveness (ROSIE) 
Dr Catherine Comiskey and Dr Gemma Cox from NUI 
Maynooth are carrying out a national longitudinal 
study, designed to evaluate the effectiveness of 
treatment and other intervention strategies used 
in Ireland for Opiate Dependence Syndrome with 
adult opiate users. This study is being carried out 
in collaboration with the Centre for Drug Misuse 
Research in Glasgow. Study recruits will be followed 
at three time intervals: at start of treatment, 6 and 2 
months later. The draft final report was received in 
December 2005.
Evaluation of the National Drug Awareness 
Campaign
The NACD commissioned a research project to track 
the effectiveness of the National Drugs Awareness 
Campaign over its 3-year cycle. Dr Saoirse Nic 
Gabhainn and Dr Jane Sixsmith, Centre for Health 
Promotion Studies, National University of Ireland, 
Galway were awarded the tender in July 2003. Phase 
one reviewed the development process in the period 
leading up to the launch of the campaign. Phase two 
will examine the process and actions following the 
launch of the campaign in 2003. Phase 3 will review 
the ongoing process of implementation. A final report 
is due in mid 2006.
Travellers and Drug Issues
Vision 2 commenced research exploring the nature 
and extent of drug misuse among the Traveller 
Community in Ireland in August 2003. The fieldwork 
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was undertaken from July 2003 to mid 2004 and a 
preliminary report was submitted to the Research 
Advisory Group. Professor Jane Fountain from the 
Centre for Ethnicity and Health University of Lancashire 
(UK) undertook a detailed analysis of the data and a 
complete final report is expected in early 2006. 
Capture Recapture Method (CRM) 2-Source. 
Dr Alan Kelly and Conor Teljeur from The Small Area 
Health Research Unit, Department of Community 
Health & General Practice, of Trinity College are 
developing prevalence estimates using the Capture 
Recapture method and two data sources (CTL and 
Garda Study). The objective is to test the application 
of the method to local area statistics in order to 
develop local prevalence estimates. A draft internal 
report on LDTF prevalence estimates has been 
completed. The NACD in collaboration with NDST 
are preparing a briefing based on this report to be 
circulated early in 2006 to the LDTFs for internal use.
OngoingInternalResearch
In its mission to review the knowledge base and 
identify gaps which can be addressed through research, 
the NACD have undertaken the preparation of internal 
papers to inform discussion on key issues. Some of 
these papers may be published in due course or may 
form part of a larger project:
n	Confidence Intervals for the 2002/2003 Drug 
Prevalence All Ireland Survey will be completed early 
in 2006. 
n	Workplace Drug Testing review has been prepared 
and is going to the working group to facilitate 
contributions to the regulations on workplace  
drug testing. 
n	Hidden Harm Summary is being prepared on the 
Report of an Inquiry by Advisory Council on the 
Misuse of Drugs in London (2003); this research 
seeks to estimate the number of children of drug 
users and identify their needs. 
n	A paper on polydrug use has been presented to the 
population survey research advisory group to assist 
in the analysis of data. 
n	HIV study: Preliminary work was carried out on 
understanding differences of HIV prevalence in 
two Dublin communities. Data were examined and 
interviews were carried out with those involved with 
drug issues in these communities for some time. 
Finally it is intended to hold focus groups with drug 
users in these communities in 2006. 
n	Support work to other projects is also an important 
dimension of the work of the NACD, including:
l	full transcription of 33 tapes for the Traveller 
Study, 
l	review of LDTF, RDTF plans for reference to 
needs of Travellers and
l	an exploration of estimating the numbers of 
children of problem drug users in Ireland. 
l	An Executive Summary of The Community Study 
was prepared to assist the NACD present the 
issues emerging to the IDG. 
Best Practice in Rehabilitation Briefing
Based on a series of discussions within the Treatment/
Rehabilitation sub-committee and a review of the 
literature related to best practice in drug rehabilitation, 
a briefing paper was forwarded to the Working Group 
on Rehabilitation established by the Drugs Strategy 
Unit. Drug rehabilitation is an holistic approach which 
provides a ‘continuum of care’ to problem drug users 
enabling them to address their (health, drug use, social, 
housing, educational, and/or vocational) needs as 
is most appropriate for them; and which is aimed at 
maximising their quality of life, and that of their families 
and communities; and enabling re-integration into the 
community. In this sense, drug rehabilitation encompasses 
interventions aimed at stopping, stabilising and/or reducing 
the harm associated with a person’s drug use as well as 
addressing a person’s broader health and social needs.
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To achieve best practice in the proposed rehabilitation 
strategy the NACD advised that a number of issues will 
need to be considered:
i) the establishment of transparent training and 
employment structures for key workers – addressing 
issues of accredited training, inclusion in drug 
services; accountability etc;
ii) the development of standard template assessment 
instruments for drug users at different stages of 
their drug using careers; 
iii) the development of templates for individual 
rehabilitation care plans; and
iv) the development of protocols to facilitate the 
level of interagency co-operation and information 
sharing needed to implement shared care plans
Drug Trend Monitoring System
The Drug Trend Monitoring System (DTMS) model 
agreed by the EWET sub-committee and the NACD 
was piloted and aimed at the production of two 
outputs in December 2004. These include a report on 
drug trends throughout Ireland, and a methodology 
report on the operation and cost of the DTMS system. 
Progress updates were submitted to the EWET. The 
main focus has been on operationalising the two key 
aspects of the DTMS model notably the development 
of a Media Monitoring system of drug related media 
reports and the establishment of a nationwide trend 
monitoring network. Meetings were held with the 
RDTFs and LDTFs in July 2003 with the purpose of 
outlining what the NACD is hoping to achieve with the 
development of the DTMS. 
Interagency Working for Prevention
The Prevention sub-committee is exploring the issue 
of interagency co-operation. There have been several 
reports, evaluations of these processes in Ireland 
yet there are still difficulties. It presents a particular 
challenge for those involved in Drugs Prevention. This 
issue is still under exploration. 
Key Performance Indicators
The NACD are developing the Balanced Scorecard 
approach for pilot implementation in 2006. The 
Balanced Scorecard approach measures a set of key 
performance indicators that reflect a balanced view of 
the NACD’s progress across all of its key functions. The 
Key Performance Indicators are:
n	Client service
n	Internal efficiency
n	Financial management, and
n	Integration.
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The Department of Community, Rural and Gaeltacht 
Affairs appointed Talbot Associates to review and 
make recommendations on the work of the NACD in 
February 2004. This project was completed in May 
2004. The review examined the following:
n	The structure of the NACD, and the validity of its 
terms of reference, work programme and goals
n	The strategic and functional aspects of NACD 
operations, i.e. structure, staff, skills, systems, style, 
strategy and shared values
n	The extent to which objectives were achieved and 
work programme implemented
n	The effectiveness, efficiency and value for money 
components of the NACD
n	The extent to which performance indicators can be 
developed and measured
n	The internal and external environment within which 
the NACD operates
n	Comparisons with similar organisations/activities 
nationally and internationally
n	The position of the NACD in the Irish drug 
information and policy environment context 
n	Recommendations regarding the future of the NACD
The review concludes that the NACD should continue 
in its present form because it is effective, meets a real 
need and provides the Government with excellent 
value for money. This value could be further enhanced 
by strengthening the internal research capacity, by 
having a more focused programme of work and by 
establishing key performance indicators to support 
strategic development. The principal recommendation 
was to extend the NACD to coincide with the life of the 
National Drugs Strategy, which ends in 2008. 
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Consequences
A Study into the Experiences of Families Seeking Support in Coping with Heroin Use  
Dr Carmel Duggan, WRC Social & Economic Consultants Limited e33,680.00
Exploratory study of HIV issues in two communities 
Mr Declan Reddy e5,980.00
EarlyWarningEmergingTrends
Drug Trend Monitoring System (DTMS) Pilot Study 
Internal e62,908.99 
Prevalence
Capture/Re-capture 2 Source Study 
Dr Alan Kelly, TCD e3,479.40
Drug Use amongst the Traveller Community Study (Analysis of data and preparation of report) 
Prof. Jane Fountain, Centre for Ethnicity and Health, University of Central Lancashire e37,48.87
Prevention
Evaluation of the National Drug Awareness Campaign 
Dr Saoirse Ni Gabhainn and Dr Jane Sixsmith, The Centre for Health Promotion Studies, NUI, Galway e72,600.00
Short Literature Review of Interagency work processes in Ireland 
Ms Liz Riches e,250.00
Research Support – Development of Outline Thinking Document on Interagency working 
Burtenshaw Kenny Associates e,633.50
Treatment
Extension of Longitudinal Study 
Dr Catherine Comiskey & Dr Gemma Cox, NUI, Maynooth e0,473.30
CommunityandVoluntarySectorResearchGrantScheme
Evaluation of Scheme 
Ms Kate Ennals e8,70.00
SupportingActions/Activities
Public Relations
Montague Communications
August ’03 – December ’03 e2,400.92
2004 e64,282.08
2005 e2,87.
e98,500.
TotalAllocated e547,697.17
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NACDExpenditure
An annual budget of approximately e.3 million is 
set aside by the Department of Community Rural 
and Gaeltacht Affairs towards the operation of the 
NACD. Seventy per cent of this budget is allocated to 
research funding and the remaining 30% to general 
administration.
The figures presented are a description of NACD 
expenditure on research and general administration 
during the period st August 2003 to 3st December 
2005. NACD finance is integrated within the general 
accounts of the Department of Community Rural and 
Gaeltacht Affairs.
NACD expenditure on new and existing research 
projects, including external expert support, during the 
period st August 2003 to 3st December 2005 
e1,380,362.75
NACD expenditure on general administration, including 
pay, public relations and legal services, during the 
period st August 2003 to 3st December 2005 
e944,123.28
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Chairperson
Dr Des Corrigan, School of Pharmacy and 
Pharmaceutical Sciences, Trinity College
ViceChairperson
Dr Mary Ellen McCann, Academic Appointment 
Members
Dr Joe Barry, Academic Appointment
Ms Jackie Blanchfield, VDTN
Ms Catherine Byrne,  
Department of Justice, Equality & Law Reform 
Mr Willie Collins, HSE, Southern Area
Mr Michael Conroy,  
Department of Community Rural & Gaeltacht Affairs
Ms Maria Corrigan, Clinical Psychologist
Mr Tony Geoghegan, (IAAAC)
Ms Mairead Kavanagh, VDTN
Dr Eamon Keenan, Consultant Psychiatrist,  
HSE, South Western Area
Mr Cathal Morgan, HSE, Eastern Region
Mr David Moloney,  
Department of Health & Children
Supt Barry O’Brien, Garda National Drugs Unit
Mr Liam O’Brien, Community Sector
Ms Patricia O’Connor, NDST
Dr Máirín O’Sullivan,  
Department of Education & Science
Ms Anna Quigley, Community Sector
Dr Hamish Sinclair, DMRD, Health Research Board
RetiredNACDMembers
(August2003–December2005)
Dr Derval Howley, NDST
Mr David Keenan, VDTN 
Mr Brian Melaugh, VDTN
Mr Barry O’Connor,  
Department of Justice, Equality & Law Reform
Ms Kathleen Stack,   
Department of Community, Rural & Gaeltacht Affairs
MembersofSub-committees
(NotsittingonMainCommittee)
(1) Consequences:
Mr Evan Breen 
Department of Community, Rural & Gaeltacht Affairs
(2) Early Warning/Emerging Trends:
Mr Gerry Hayes 
Department of Justice Equality & Law Reform
Ms Pauline Leavy 
Medical Bureau of Road Safety
Det Garda Pat Davis 
Garda National Drugs Unit 
Ms Siobhan Stokes 
State Laboratory
Dr Daniel O’Driscoll 
Forensic Science Laboratory
Mr Tom McGuinn 
Department of Health & Children
Ms Anya Pierce 
Toxicology Department, Beaumont Hospital
Mr John Kelly 
Department of Community, Rural & Gaeltacht Affairs
Dr Bobby Smith HSE, South Western Area
Dr Richie Maguire, Drug Treatment Centre Board
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(3) Prevalence:
 
(4) Prevention:
Ms Elaine Butler 
Drug Education Workers Forum
Ms Cathy Lyons 
Department of Health & Children
Ms Sinead Copeland 
Department of Community, Rural & Gaeltacht Affairs
Ms Ruby Morrow 
Church of Ireland College of Education
(5) Treatment:
Dr Ide Delargy 
Irish College of General Practitioners
Mr John Kelly  
Department of Community, Rural & Gaeltacht Affairs
Ms Frances Nangle-Connor 
Irish Prison Service
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Dr Des Corrigan School of Pharmacy & Pharmaceutical Sciences,  
Trinity College ¸ ¸ ¸
Dr Mary Ellen McCann Academic Appointment ¸ ¸
Dr Joe Barry Academic Appointment ¸ ¸
Ms Catherine Byrne Department of Justice, Equality & Law Reform ¸ ¸
Mr Willie Collins HSE, Southern Area ¸ ¸ ¸
Ms Maria Corrigan Clinical Psychologist ¸ ¸
Mr Tony Geoghegan IAAAC ¸ ¸
Ms Mairéad Kavanagh VDTN ¸ ¸
Dr Eamon Keenan HSE, South Western Area ¸ ¸
Mr David Moloney Department of Health & Children ¸ ¸ ¸
Mr Cathal Morgan HSE, Eastern Region ¸
Supt Barry O’Brien Garda National Drug Unit ¸ ¸
Mr Liam O’Brien Community Sector ¸
Ms Patricia O’Connor NDST ¸ ¸ ¸
Dr Máirín O’Sullivan Department of Education & Science ¸
Ms Anna Quigley Community Sector ¸ ¸
Dr Hamish Sinclair DMRD, Health Research Board ¸ ¸ ¸ ¸
Mr Evan Breen Department of Community Rural & Gaeltacht Affairs ¸
Mr Gerry Hayes Department of Justice, Equality & Law Reform ¸
Ms Pauline Leavy Medical Bureau of Road Safety ¸
Det Garda Pat Davis Garda National Drug Unit ¸
Ms Siobhan Stokes State Laboratory ¸
Dr Daniel O’Driscoll Forensic Science Laboratory ¸
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Mr Tom McGuinn Department of Health & Children ¸
Ms Anya Pierce Toxicology Department Beaumont Hospital ¸
Mr John Kelly Department of Community Rural & Gaeltacht Affairs ¸ ¸
Dr Bobby Smith HSE, South Western Area ¸
Dr Richie Maguire Drug Treatment Centre Board ¸
Ms Elaine Butler Drug Education Workers Forum ¸
Ms Cathy Lyons Department of Health & Children ¸
Ms Ruby Morrow Church of Ireland College of Education ¸
Dr Ide Delargy Irish College of General Practitioners ¸
Ms Frances Nangle-Connor Irish Prison Services ¸
Ms Sinead Copeland Department of Community Rural & Gaeltacht Affairs ¸
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In the National Drugs Strategy 200-2008, the NACD 
was requested to undertake the following actions.
98 To carry out studies on drug misuse amongst 
the at risk groups identified e.g. Travellers, 
prostitutes, the homeless, early school leavers 
etc. including de-segregation of data on these 
groups. It is essential that the individuals and 
groups most affected by drug misuse and those 
involved in working to reduce, treat and prevent 
drug misuse have immediate access to relevant 
statistical information. 
99 To commission further outcome studies, within 
the Irish setting to establish the current impact 
of methadone treatment on both individual 
health and on offending behaviour. Such studies 
should be an important tool in determining the 
long term value of this treatment. 
00 To conduct research into the effectiveness of 
new mechanisms to minimize the sharing of 
equipment e.g. non-reusable syringes, mobile 
syringe exchange facilities etc. to establish the 
potential application of new options within 
particular cohorts of the drug using population 
i.e. amongst younger drug misusers, within 
prisons etc. 
08 To implement the recommendations in the 2004 
NACD Report (Role of Family Support Services 
in Drug Prevention), namely:
n	to increase the capacity of services to respond 
through an appropriate level of resources and 
training for staff in services;
n to strengthen interagency links and networks 
by building knowledge of local community 
issues and attitudes thus improving 
communications; and
n to develop relevant monitoring and 
evaluation tools to measure effectiveness of 
services.
 The NDST should actively encourage the LDTFs 
and RDTFs to prioritise the provision of family 
services in their areas.
 To support family support networks in their 
work in the area of information provision and 
assistance to local family support groups.
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